Wolters Kluwer accounting industry survey reveals revenue growth remains key focus in APAC region
Survey finds that accounting firms embracing innovation, technology and cloud solutions will thrive SYDNEY–(BUSINESS WIRE)–Wolters Kluwer, a global leader... Read more.
GE HealthCare Announces Study Results Demonstrating Portrait Mobile Continuous Monitoring Solution Performance with Patients and Care Teams in the Ward
Study finds that continuous monitoring of vital signs (respiratory rate, oxygen saturation and pulse rate) with Portrait Mobile results in alarm data which may be... Read more.
PCTI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of PCTEL, Inc. Is Fair to Shareholders
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of PCTEL, Inc. (NASDAQ: PCTI) to Amphenol Corporation... Read more.
Ray Day, APR, Vice Chair of Stagwell, Elected 2025 PRSA Chair
2024 Board of Directors Announced at Annual Leadership Assembly NASHVILLE, Tenn.–(BUSINESS WIRE)–#PRSAICON2023–PRSA today announced the newly elected... Read more.
Avistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
BEIJING, China–(BUSINESS WIRE)–Avistone Biotechnology Co., Ltd (“Avistone” or “the Company”), a clinical-stage biotechnology company focused... Read more.
Ankyra Therapeutics Presents Preliminary Phase 1 Canine Clinical Data Evaluating cANK-101 to Treat Advanced Malignant Melanoma in Dogs
First-in-class anchored IL-12 immunotherapy increases immune cell infiltration into tumors while decreasing systemic toxicity Human ANK-101, an IL-12- based anchored... Read more.
New Phase 1 Dose Escalation Cohorts Data for Aulos Bioscience’s AU-007 Show Favorable Pharmacodynamic Effects at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Interim data from an ongoing trial support overall mechanism of action of AU-007, a computationally designed human monoclonal antibody, in decreasing Tregs while... Read more.
Puma Biotechnology Announces Presentation of Findings from a Phase I/II Study of Alisertib and Pembrolizumab for Rb-Deficient Head and Neck Squamous Cell Carcinomas at the 2023 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the poster presentation of a Phase I/II trial... Read more.
Verastem Oncology Announces Initial Results of RAMP 203 Trial of Avutometinib and LUMAKRAS™ (sotorasib) in KRAS G12C-Mutant Non-Small Cell Lung Cancer
Avutometinib + Sotorasib Combination Demonstrated Preliminary Efficacy with Confirmed Responses in both KRAS G12C Inhibitor Resistant and Naïve Patients No New... Read more.
Morphic Holding SHAREHOLDER ALERT: Johnson Fistel Encourages Morphic Holding Shareholders with Losses to Contact the Firm Regarding Investigation
SAN DIEGO–(BUSINESS WIRE)–Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Morphic Holding, Inc. (NASDAQ:... Read more.